11-12 September 2018 //  Lancaster Royal Hotel, London


Frank Schnieders

Dr Frank Schnieders

CEO, Provecs Medical

Frank Schnieders is founder and CEO of Provecs Medical in Hamburg, Germany. He is biochemist with more than 15 years of experience in biopharmaceutical industry and entrepreneurship. His focus in the fields of gene therapy, biomedical and clinical research has been the translation of research into novel treatment options for cancer patients. Frank authored numerous scientific publications, filed more than 30 patents related to gene and immunotherapy, he was granted with business awards, and is member of major immunotherapy associations, CIC, CIMT, SITC. With a PhD in human genetics from the Medical School Hanover, postdoctoral experience in gene therapy and molecular medicine at the Max-Planck-Institute, Berlin, he started his own research group at the University Medical Center in Hamburg-Eppendorf and founded Provecs Medical as a spin-out. In 2016, the first immune-oncology product Immunalon® entered a development and license cooperation with a pharma partner towards clinical development and approval.


2017 Speakers

"It was a very interesting event as all participants, including speakers were ready to exchange, even on the most challenging subjects such as reimbursement, GMP guidance."

Bertrand Alexandre, Director, Marketing Europe, Celyad